EBOS Group Limited (AU:EBO) has released an update.
EBOS Group Limited has reported a robust financial performance for the fiscal year 2024, with revenue surpassing $13 billion, an increase of 7.8%, and an uptick in underlying EBITDA and NPAT by 7.3% and 7.7% respectively. The Healthcare and Animal Care segments led the earnings growth, complemented by strategic acquisitions and investment in growth opportunities. Looking ahead, EBOS is optimistic about FY25, projecting an underlying EBITDA between $575 million and $600 million and continuing its expansion in New Zealand, Australia, and Southeast Asia.
For further insights into AU:EBO stock, check out TipRanks’ Stock Analysis page.
